Smith Hayes Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$870K Buy
12,083
+60
+0.5% +$4.54K 0.18% 144
2015
Q4
$1.01M Buy
12,023
+3
+0% +$249 0.21% 130
2015
Q3
$1.01M Buy
12,020
+4
+0% +$338 0.22% 130
2015
Q2
$1M Buy
12,016
+663
+6% +$50.5K 0.2% 134
2015
Q1
$825K Sell
11,353
-120
-1% -$8.54K 0.16% 154
2014
Q4
$792K Buy
11,473
+3
+0% +$202 0.17% 156
2014
Q3
$744K Sell
11,470
-318
-3% -$20.1K 0.17% 145
2014
Q2
$733K Buy
11,788
+3
+0% +$179 0.17% 147
2014
Q1
$694K Buy
11,785
+3,305
+39% +$184K 0.17% 150
2013
Q4
$432K Buy
8,480
+6
+0.1% +$300 0.14% 168
2013
Q3
$427K Sell
8,474
-1,642
-16% -$86K 0.16% 149
2013
Q2
$497K Buy
+10,116
New +$550K 0.21% 123

Other funds holding LLY

Smith Hayes Advisers's LLY Position: Q1 2016 in Review

Smith Hayes Advisers increased its Eli Lilly (LLY) stake by 0.5% in Q1 2016, buying an estimated $4.54K and bringing the position to 12,083 shares worth $870K. The position accounts for 0.18% of the portfolio, ranked #144.

Smith Hayes Advisers first reported a position in LLY in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.01M in Q4 2015. 1,151 funds tracked by Wall St. Rank hold LLY as of Q1 2016.

  • Smith Hayes Advisers held 12,083 shares of Eli Lilly worth $870K as of Q1 2016.
  • Smith Hayes Advisers bought 60 Eli Lilly shares in Q1 2016, an estimated $4.54K.
  • Eli Lilly made up 0.18% of Smith Hayes Advisers's portfolio in Q1 2016, its #144 holding.
  • Smith Hayes Advisers first reported a position in Eli Lilly in Q2 2013 and has held it in 12 quarters since.
  • Smith Hayes Advisers's Eli Lilly position peaked at $1.01M in Q4 2015.
  • 1,151 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2016.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.